Illinois 60611, U.S.A. 1 A study was made to exclude the notion that adenosine receptor agonists exert a direct physical blockade of the depolarization-secretion process. Reduced temperature was employed as a tool for distinguishing between physico-chemical processes (such as those which mediate evoked transmitter release) and biochemical mechanisms (such as those which involve second messenger substances) in the action of adenosine. Adenosine and 2-chloroadenosine were used as agonists in this electrophysiological study of the release of acetylcholine (ACh) from frog motor nerve terminals. 2 The ability of these two adenosine receptor activators to reduce neurally-evoked ACh release was prevented or greatly attenuated by maintaining the preparation at temperatures between 5 and 10°C. Such low temperatures inhibit the activation of receptors coupled to second messengers via guanine nucleotide binding proteins (e.g. adenylate cyclase). Low temperature alone did not substantially alter evoked ACh secretion under the conditions of these experiments. 3 Inhibition of evoked ACh release by the extracellular Ca antagonist Mg, which acts directly to block Ca channels, was not affected by low temperature. 4 The results are consistent with the hypothesis that a temperature-sensitive second messenger system controls the intracellular events linked to extracellular adenosine receptor activation.
Introduction
Adenosine is a ubiquitous neuromodulatory substance which may play a role in the presynaptic inhibition of acetylcholine (ACh) release (Silinsky, 1975; Ribeiro, 1979; ; for general reviews see Stone, 1981; Phillis & Wu, 1982; Dunwiddie, 1985) . At the motor nerve ending, adenosine receptor activation is likely to depress quantal ACh release by causing a decrease in the apparent affinity for Ca of a structural component of the secretory apparatus (Silinsky, 1981; but see Ribeiro & Sebastiao, 1986) .
As the adenosine receptor responsible for inhibition of ACh release is situated extracellularly (Silinsky, 1980; Daly, 1985; , adenosine may be exerting its inhibitory effect directly by a physico-chemical linkage to cellular Ca binding proteins or indirectly via the action of a secondary or tertiary messenger, e.g. guanine nucleotide binding (G) proteins, cyclic adenosine monophosphate (cyclic AMP) (see Silinsky, 1986) . It 'Author for correspondence.
should be possible to distinguish between these two broad mechanisms by relying on the more pronounced effects of temperature on enzyme-catalysed reactions as compared to physico-chemical processes such as ion diffusion and binding (see Hille, 1984, pp. 198-202) . For example, hormonal stimulation of adenylate cyclase by its G protein (Gs) is severely depressed at temperatures below room temperature (Harwood & Rodbell, 1973; Codina et al., 1984) with complete inhibition occurring near 40C (Codina et al., 1984) . In contrast, a predominantly physicochemical process such as the evoked release of acetylcholine (Parsegian, 1977) may not be greatly altered in the temperature range expected to inhibit the G protein/adenylate cyclase system (see e.g. Jensen, 1972; Barrett et al., 1978 Figure 3 ) and in favour of mediation through second messengers.
Methods

Electrophysiological procedures
Cutaneous pectoris nerve-muscle preparations of frog (Rana pipiens) (del Castillo & Katz, 1954) using the formamide method to block muscle contraction (see del Castillo & Motta, 1978; Silinsky & Vogel, 1986 ). In the experiments in Tc (1.5-8 mg I`), changes in e.p.p. amplitudes, which accurately reflect changes in synchronous ACh release in adenosine (Ginsborg & Hirst, 1972; Silinsky, 1980; The statistical procedures were identical to those described previously (see Silinsky, 1984, pp. 244-245) . In most instances, appropriate averaging techniques were employed (see Silinsky, 1984; . Statistically significant differences were generally observed at P 4 0.01. In instances where significance was at the P < 0.05 level, this is stated in the text (see e.g. legend to Figure 3 ). Corrections for nonlinear summation were employed when necessary (McLachlan & Martin, 1981) .
Composition ofsolutions and chemicals
Normal frog Ringer contained (mM): NaCl 115, KCl 2, CaC12 1.8, NaHCO3 2 (pH 7.2-7.4) and was used in all experiments. Drugs were obtained from the Sigma Chemical Company.
Results
The effect of temperature on quantal ACh release in normal calcium solutions As a prelude to studies with adenosine derivatives, it is necessary to confirm directly that synchronous evoked ACh release, a process unlikely to involve extensive enzyme catalysis (Parsegian, 1977; Silinsky, 1985b) remains near normal at the low temperatures which inhibit G protein-linked second messenger systems (Harwood & Rodbell, 1973; Codina et al., 1984) . Figure 1 , which illustrates an experiment made in normal Ca solution after formamide treatment, provides support for this contention. In Figure  1 , whilst the predicted changes in the kinetics of the e.p.ps (a) and the m.e.p.ps (b and c) are evident as the temperature is varied between 8 and 20°C (del Castillo & Machne, 1953; Li & Gouras, 1958; Katz & Miledi, 1965; Jensen, 1972; Barrett et al., 1978) , the ratio of the mean e.p.p. to the mean m.e.p.p. amplitude (di) remained near the control level (mn = 14 at 8°C, di = 17 at 20°C; see also Jensen (1972) , Figure 2 and Table 1 ).
In contrast to the results on evoked release, the rate of spontaneous ACh release was markedly reduced by lowering the temperature (see Figure 1 , legend), confirming observations made by Barrett et al. (1978) in the frog cutaneous pectoris nerve-muscle preparation.
As the evoked ACh release mechanism functions at near normal capacity at low temperature, it would Figure 1 Temperatures between 8-20'C produce minimal effects on evoked acetylcholine (ACh) release (mn) in normal Ca solutions. The mi was measured directly from the ratio of the mean endplate potential amplitude (e.p.p., (a)) to the miniature endplate potential amplitudes (m.e.p.p., (b) and (c)) using the formamide method to block excitation-contraction coupling. The mni at 20'C was 17.4 whilst min at 80C was 14.1. (a) Shows progressive slowing of e.p.p. kinetics and lengthening of latency period without substantial changes in amplitude as temperature is lowered progressively from 200C (left trace), from 17-90C (middle 9 traces) and 80C (right trace (Ginsborg & Hirst, 1972; Silinsky, 1980; . The latter compound is from 1-2 orders of magnitude more potent than the parent nucleoside with maximal inhibition of m1n by 2-chloroadenosine generally observed at 500 nm (see Silinsky, 1984, Figure 1 ). At 5°C, however, in the experiment illustrated in Figure 2 (50pM) at low temperature (5-100C) was reproduced in 5 of 6 experiments, with a modest inhibitory effect being observed in the sixth (see Figure 3b below ).
It would be of interest to determine what contribution changes in agonist binding make to the paucity of effects of adenosine receptor agonists at low temperature. The fortuitous discovery of a nerve ending in which adenosine is a particularly efficacious inhibitor of ACh release at normal temperature ( Figure 3a , 26% of control) made such an investigation possible. Figure 3 illustrates the concentrationeffect relationship for adenosine at two different temperatures in the same fibre. At low temperature (6°C, Figure 3b ), despite the small maximal inhibitory effect (only to 77% of control, open and closed squares), the relationship between adenosine concentration and percentage maximal inhibition is similar to that published previously (see Figure legend and Silinsky, 1984 ; Figure 1 ). The observation that there was little or no change in the concentration of adenosine required for half-maximal inhibition at 6°C as at 20°C (see Figure legend) suggests that differences in binding at normal and low temperatures are not responsible for the failure of adenosine derivatives to inhibit ACh release at reduced temperatures. Rather, it appears that low temperature reduces the maximal inhibitory efficacy of adenosine receptor agonists.
Effects of low temperature on the action of Mg
Mg has been found to block evoked ACh release by occluding the site of Ca entry in a competitive manner at motor nerve endings (Jenkinson, 1957; Kharasch et al., 1981) . If reduced temperature were selectively impairing the effects of agents that act through second messengers, then, blockade of release by Mg would not be affected by low temperature as antagonism by the cation is by a direct interaction with the ion channels. Figure 4 shows this to be the case. Specifically, in contrast to the impaired action of adenosine at low temperature, inhibition by 5 mM Mg at low temperature was in the range found previously at normal temperature in frog preparations. This is also the level of inhibition expected from simple equilibrium considerations (Figure 4 ; cf. Silinsky, 1984, Methods and Figures 3 and 7; Jenkinson, 1957) 
Discussion
These results reinforce the notion that secondary and or tertiary messenger substances such as those linked to G-proteins are involved in the inhibition of ACh secretion by adenosine derivatives. At the reduced temperature (5-10'C) expected to have only minor effects on physico-chemical processes (Hille, 1984) yet able to inhibit the enzyme adenylate cyclase and other second messenger systems linked to G proteins (Harwood & Rodbell, 1973; Codina et al., 1984; Hille, 1984) , the inhibitory effect of adenosine derivatives is prevented or severely impaired. The observation that Mg still retains its typical inhibitory effects at low temperature provides further evidence for the temperature-independence expected of direct acting Ca antagonists. It also appears that a physicochemical antagonism of the Ca channel in a manner equivalent to Mg is not responsible for the blockade of evoked release by adenosine.
It is unclear as to what specific component of the action of adenosine nucleosides is being affected by lowered temperature. The results of Figure 3b suggest that it is not the initial adsorption of adenosine onto its extracellular binding site that is impaired; rather, it is the effectiveness by which receptor-bound adenosine elicits its response that is decreased by a reduction in the temperature of the bathing fluid. It is also unlikely that low temperature is inhibiting ACh release by reducing the uptake of adenosine to a target site within the nerve ending.
Firstly, an extracellular receptor of the A/R category (Daly, 1985) is responsible for the inhibitory effects of adenosine at motor nerve endings (Silinsky, 1980; and a reduction in uptake would be expected to increase the effectiveness of a submaximal concentration of adenosine, not impair it. In addition, 2-chloroadenosine is a minimal substrate for uptake and deamination in Time (min) Figure 3 Concentration-effect relationship for adenosine in normal calcium solutions at room temperature (20'C; a) and at low temperature (60C; b) in the same fibre. Each symbol is the averaged response to 4 stimuli delivered at 0.1 Hz. (a) Shows that, in this cell, adenosine was a particularly efficacious inhibitor of ACh release at room temperature; a reduction to approximately 26% of the control value was observed rather than the usual 50% inhibition. Adenosine concentrations were 101pM (A) and 25 pm (El); significant differences in inhibition were observed between the two concentrations (P < 0.05). Maximal inhibition is usually observed at a concentration of 25 AM adenosine (see Silinsky, 1980; . The tubocurarine (Tc) concentration was 4mgI-'. In (b) made at 60C, 1 M adenosine produced a statistically-significant decrease (P < 0.05) in ACh release (A) relative to control (0) with a further statistically-significant effect being observed with 10pM adenosine (A). The maximal inhibitory effect (approximately 77% of control) was achieved at 25pim; i.e., no significant differences were observed between 25 and 5OM adenosine (0). The issue of whether 10pM adenosine is producing a maximal response is uncertain given the small effects seen at low temperature. For example if the last three averaged responses in 10pM adenosine are compared to the last three averages in 25 pm adenosine (El), then the differences are statistically significant. If however 10pM is compared to all of the averaged data points in 5OpM adenosine, then no significant differences arise. The average points in 50 pM adenosine, however, may show additional scatter because of the tendency of high concentrations of adenosine receptor agonists to produce rebound increases in ACh secretion. These increases may begin during exposure (Silinsky, 1980) but are most pronounced after exposure to agonist (this is seen at the end of Figure 3b , (0) neural elements (Daly, 1982) yet its effects are impaired at low temperature.
It may be speculated that a G protein linked to the adenosine receptor either directly or through a second messenger (e.g. cyclic AMP) is prevented from attaining its activated state. Indeed, it has been shown that the lowest temperatures employed in this study (50C) prevent the dissociation of the alpha subunit from the regulatory guanine nucleotide binding complex of the G protein; dissociation of the alpha subunit from the alpha/beta/gamma complex is essential for the binding of agonists to be coupled to biological effects (Codina et al., 1984) . G-proteins have been implicated as mediators of the action of adenosine (Dolphin & Prestwich, 1985; Kurachi et al., 1986; Silinsky, 1985a) although the issues of guanine nucleotide binding proteins and cyclic AMP are still unclear at motor nerve endings (Silinsky et al., 1987) . Experiments are currently underway using lipid vesicles to deliver various G-protein and cyclic nucleotide reagents to the nerve terminal cytoplasm to test whether G-proteins directly or indirectly (through changes in cyclic AMP concentrations) affect the action of adenosine.
The classification of adenosine receptor on prejunctional nerve endings is controversial at present. Some recent evidence including experiments whereby cyclic AMP liposomes mimic the effects of adenosine (Silinsky et al., 1987, Figure 6 ) suggest that an A2 receptor (associated with increases in cyclic AMP) might be involved in the presynaptic effects of adenosine. (See also Discussion in Vogel, 1986 and Barraco, 1985 for additional evidence of prejunctional A2 sites which inhibit transmitter release). However, Al receptors (which produce decreases in cyclic AMP) or perhaps even further divisions such as an Al subtype (see Dunwiddie & Proctor, 1987) or an A3 receptor (coupled to Ca binding proteins or to Ca entry -see Ribeiro & Sebastiao, 1986 ) may need to be postulated to explain the prejunctional affects of adenosine and some synapses.
In conclusion, regardless of the nature of the bio- 
